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Abstract
This case is of a 34-year-old immunocompromised male with Pott’s puffy tumour, which was treated with antibiotics and
endoscopic sinus surgery. Pott’s puffy tumour is typically a complication of frontal sinusitis in children and immunocompro-
mise can be a precipitating factor. A search was conducted of Embase, Medline, CINAHL, Cochrane, Google Scholar, Informit
and Scopus of ‘Pott’s Puffy’ and variations of this phrase. Initial 804 records were reviewed by title, abstract and full text. Of the
unique papers identified, 155 only included paediatric patients and 128 included adult patients. After title, abstract and full-
text review of 13 papers were identified describing Pott’s puffy tumour in immunocompromised patients. Immunosuppression
was noted as a risk factor in only a small number of cases, with diabetes mellitus being the most common. A few cases did
note immunosuppression due to newer immunomodulatory agents being used for treatment of autoimmune conditions.
INTRODUCTION
This case is of a 34-year-old immunosuppressed male who pre-
sented with Pott’s puffy tumour as a complication of frontal
sinusitis. Surgical incision and drainage was performed with
endoscopic debridement of sinuses, in addition to treatment
with antibiotics and nasal decongestants. This case highlights
immunosuppression, particularly with tumour necrosis factor
(TNF) inhibitors, as a potential risk factor for development of
Pott’s puffy tumour as a complication of frontal sinusitis.
CASE REPORT
A 34-year-old gentleman presented to the emergency depart-
ment of a regional hospital with 2 days of left-sided periorbital
swelling superior to the eye socket with associated erythema and
tenderness. He was assessed to have normal visual acuity and
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extraocular movements. He had a history of severe ankylosing
spondylitis for which he was taking a TNF inhibitor, adalimumab.
His blood tests showed a slightly raised C-reactive protein of
82 mg/l but otherwise no abnormality. Magnetic resonance imag-
ing (MRI) was performed on the day of admission and noted
significant left frontal sinusitis complicated by a defect of the
frontal cortical bone as well as oedema and enhancement con-
sistent with a Pott’s puffy tumour (Fig. 1). There was also an
abscess of the periorbital soft tissue. Immediate treatment was
given in the form of phenylephrine nasal decongestants and
intravenous antibiotics (amoxicillin with clavulanic acid), and
the patient was transferred to a tertiary centre with ear, nose
and throat surgery capacity.
Within 24 hours of arrival at the tertiary centre, an incision
and drainage of the soft tissue abscess and periosteal abscess
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Figure 1: Sagittal and transverse of MRI Pott’s puffy tumour
Figure 2: Intraoperative photos. Left: view of dura on endoscopic examination of frontal sinus via bony erosion. Right: complete bony occlusion of frontal recess
via endoscopic approach and a wide maxillary antrostomy and
sphenoidectomy was performed. It was discovered that the
frontal recess was completely occluded by a bony wall (Fig. 2). A
cannula was placed into the frontal sinus for regular irrigation
during the post-operative period with the other sinuses irrigated
via nasal douche. Intravenous antibiotics and regular irrigation
were continued for a further 5 days, and the TNF inhibitor was
withheld on the advice of a rheumatologist. After this time
the frontal sinus cannula was removed and the patient was
discharged home. He was reviewed as an outpatient 6 days
later and had a palpable soft tissue collection in the same area,
which was promptly drained surgically and appeared to be a
mucocele intraoperatively. None of the cultures identified a
specific causative organism, although a Gram stain from the
original admission showed gram negative bacilli. The patient
was planned to have definitive surgery to open the bony
occlusion of the frontal sinus and allow proper drainage. The
patient was noted not to have any recurrence of symptoms on
follow-up 1 year post-operatively.
DISCUSSION
Pott’s puffy tumour is a rare clinical entity and is most commonly
a complication of frontal sinusitis in children [1]. This case is
unique in that it presents in an adult with no traumatic history
and immunosuppression as the only risk factor. TNF inhibitors
do not appear to have a significant association with sinusitis but
due to being immunosuppressants may slightly increase the risk
of upper respiratory tract infections [2]. A literature review was
conducted to investigate the role of immunosuppression in Pott’s
puffy tumour patients.
A search was conducted on 10 March 2020 of CINAHL,
Cochrane Embase, Informit, Google Scholar (first 50 results only),
Medline and Scopus of ‘Pott’s Puffy’ and variations of this phrase.
Initial 804 records were reviewed by title, abstract and full text
(as detailed in Fig. 3) and narrowed down to 13 papers of adult
Pott’s puffy tumour where immunosuppression was noted in
the case.
Of the unique papers identified, 155 only included paediatric
patients, whereas 128 included adult patients. This would indi-
cate that Pott’s puffy tumour in adult patients is not quite as rare
as previously thought. The paediatric cases were reviewed by
abstract only for immunosuppression and only four were found.
Two girls also on the same immunosuppressant medication as
this patient (TNF inhibitor adalimumab) developed Pott’s puffy
tumour [3]. Another case of a 14 year old on an immunosuppres-
sive study drug for juvenile idiopathic arthritis was published in
the USA [4]. Finally one child with Type 2 diabetes mellitus in a
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Figure 3: Flowchart of literature review
Of the 13 adult patients’ papers comprising of both case
reports and case series, 12 patients were immunosuppressed
and 1 was pregnant (Table 1). The most commonly noted was
diabetes in seven patients, and there was one patient with
rheumatoid arthritis being treated with oral prednisolone, igu-
ratimod and bucillamine.
Most Pott’s puffy tumour cases appear to be in previously fit
and well patients, so immunosuppression may play less of a role
than neglect of symptoms and delayed clinical review. In this
patient the location being several hours drive from the nearest
hospital may be more relevant than their immunosuppression.
Nonetheless, a higher index of suspicion for severe complica-
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